![Stephen Tulipano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Tulipano
Corporate Officer/Principal at
The American Institute of Certified Public Accountants
Profile
Stephen J.
Tulipano is currently a Member at The American Institute of Certified Public Accountants and a Member at the Massachusetts Society of Certified Public Accountants, Inc. Previously, he worked as the Director-Corporate Accounting at Biogen, Inc. from 1998 to 2006.
He also served as the Manager-External Reporting at Digital Equipment Corp.
Additionally, he held the position of Chief Financial Officer & Treasurer at Aldeyra Therapeutics, Inc. from 2014 to 2018 and Chief Financial Officer & Secretary at Javelin Pharmaceuticals, Inc. from 2009 to 2010.
Currently, he is the Chief Financial Officer at Stoke Therapeutics, Inc. from 2019 to 2024.
Mr. Tulipano obtained his undergraduate degree from Salem State University and his MBA from Sawyer Business School.
Stephen Tulipano active positions
| Companies | Position | Start |
|---|---|---|
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Massachusetts Society of Certified Public Accountants, Inc.
 Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for CPAs | Corporate Officer/Principal | - |
Former positions of Stephen Tulipano
| Companies | Position | End |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Director of Finance/CFO | 07/05/2024 |
| ALDEYRA THERAPEUTICS, INC. | Director of Finance/CFO | 31/07/2018 |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Director of Finance/CFO | 01/07/2010 |
| BIOGEN INC. | Comptroller/Controller/Auditor | 01/04/2006 |
Digital Equipment Corp.
 Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Corporate Officer/Principal | - |
Training of Stephen Tulipano
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Digital Equipment Corp.
Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Salem State University
 Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Massachusetts Society of Certified Public Accountants, Inc.
Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for CPAs | Commercial Services |
Sawyer Business School
 Sawyer Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- Stephen Tulipano
